| Ayyaz M Shah, DO | |
|
200 Front St, Vestal, NY 13850-1559 | |
| (607) 658-1003 | |
| (607) 658-1006 |
| Full Name | Ayyaz M Shah |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Experience | 30 Years |
| Location | 200 Front St, Vestal, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1619167673 | NPI | - | NPPES |
| 001992700 | Medicaid | FL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | OS10163 (Florida) | Secondary |
| 207N00000X | Dermatology | 203641 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| United Health Services Hospitals, Inc | Binghamton, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| United Health Services Hospitals, Inc. | 5193610533 | 355 |
News Archive
A University of Colorado Cancer Center study published online this month in the journal Cell Cycle shows that breast cancer cell growth, motility and aggression is promoted by excess glucose, as experienced by patients with diabetes and metabolic syndrome.
Health officials in Indonesia have confirmed the first human death from bird flu in Bali in a village in the north-west district of Jembrana, an area where poultry is known to be affected.
The first lockdown led to a significant increase in symptoms of depression among children, highlighting the unintended consequences of school closures, according to a new study from the University of Cambridge.
PROLOR Biotech, Inc., a company developing next generation biobetter therapeutic proteins, today announced initiation of a Phase II clinical trial of its long-acting CTP-modified version of human growth hormone (hGH-CTP) in children with growth hormone deficiency.
› Verified 2 days ago
| Entity Name | United Health Services Hospitals, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962463851 PECOS PAC ID: 5193610533 Enrollment ID: O20040216001017 |
News Archive
A University of Colorado Cancer Center study published online this month in the journal Cell Cycle shows that breast cancer cell growth, motility and aggression is promoted by excess glucose, as experienced by patients with diabetes and metabolic syndrome.
Health officials in Indonesia have confirmed the first human death from bird flu in Bali in a village in the north-west district of Jembrana, an area where poultry is known to be affected.
The first lockdown led to a significant increase in symptoms of depression among children, highlighting the unintended consequences of school closures, according to a new study from the University of Cambridge.
PROLOR Biotech, Inc., a company developing next generation biobetter therapeutic proteins, today announced initiation of a Phase II clinical trial of its long-acting CTP-modified version of human growth hormone (hGH-CTP) in children with growth hormone deficiency.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ayyaz M Shah, DO 33 Lewis Rd, 2nd Fl, Binghamton, NY 13905 Ph: (607) 770-0025 | Ayyaz M Shah, DO 200 Front St, Vestal, NY 13850-1559 Ph: (607) 658-1003 |
News Archive
A University of Colorado Cancer Center study published online this month in the journal Cell Cycle shows that breast cancer cell growth, motility and aggression is promoted by excess glucose, as experienced by patients with diabetes and metabolic syndrome.
Health officials in Indonesia have confirmed the first human death from bird flu in Bali in a village in the north-west district of Jembrana, an area where poultry is known to be affected.
The first lockdown led to a significant increase in symptoms of depression among children, highlighting the unintended consequences of school closures, according to a new study from the University of Cambridge.
PROLOR Biotech, Inc., a company developing next generation biobetter therapeutic proteins, today announced initiation of a Phase II clinical trial of its long-acting CTP-modified version of human growth hormone (hGH-CTP) in children with growth hormone deficiency.
› Verified 2 days ago
Dr. Colleen Mary Crandell, D.O. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 200 Plaza Dr, Suite B, Vestal, NY 13850 Phone: 607-729-2777 | |
Manisha Manmohan, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 200 Front St, Vestal, NY 13850 Phone: 607-658-1003 Fax: 607-658-1006 | |
Romeo Morales, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 200 Front St, Vestal, NY 13850 Phone: 607-658-1003 Fax: 607-658-1006 | |
Shelly Rivas, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3101 Shippers Rd Ste 102, Vestal, NY 13850 Phone: 607-251-2100 | |
Dr. Uzoma Oranu, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 200 Front St, Vestal, NY 13850 Phone: 607-658-1003 Fax: 607-658-1006 | |
Dr. Genadij Sienkiewicz, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 200 Front St, Vestal, NY 13850 Phone: 607-658-1003 Fax: 607-658-1006 |